Holly A. Saffran

2.3k total citations
31 papers, 1.6k citations indexed

About

Holly A. Saffran is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Holly A. Saffran has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Holly A. Saffran's work include Herpesvirus Infections and Treatments (19 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Viral Infections and Immunology Research (7 papers). Holly A. Saffran is often cited by papers focused on Herpesvirus Infections and Treatments (19 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Viral Infections and Immunology Research (7 papers). Holly A. Saffran collaborates with scholars based in Canada, United States and China. Holly A. Saffran's co-authors include James R. Smiley, Karen Mossman, D. Lorne Tyrrell, Michael Joyce, Jennifer A. Corcoran, M. Joanne Lemieux, Justin Shields, Elena Arutyunova, Wayne Vuong and Muhammad Bashir Khan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Holly A. Saffran

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly A. Saffran Canada 21 775 578 467 381 287 31 1.6k
Arthur S. Kim United States 23 580 0.7× 351 0.6× 986 2.1× 248 0.7× 88 0.3× 29 1.9k
Masatsugu Kimura Japan 22 510 0.7× 309 0.5× 216 0.5× 272 0.7× 283 1.0× 71 2.2k
Robert A. Ogert United States 17 511 0.7× 269 0.5× 415 0.9× 388 1.0× 64 0.2× 32 1.4k
Oliver C. Grant United States 23 1.0k 1.4× 453 0.8× 672 1.4× 431 1.1× 56 0.2× 35 1.9k
Xufang Deng United States 19 456 0.6× 209 0.4× 1.1k 2.4× 378 1.0× 279 1.0× 48 1.8k
Beatrice Mercorelli Italy 22 596 0.8× 888 1.5× 276 0.6× 333 0.9× 131 0.5× 44 1.6k
Gary N. Rogers United States 20 1.4k 1.9× 2.0k 3.4× 624 1.3× 717 1.9× 74 0.3× 25 3.4k
Chengjin Ye United States 21 373 0.5× 397 0.7× 877 1.9× 153 0.4× 88 0.3× 64 1.4k
Zongyang Lv United States 15 810 1.0× 372 0.6× 390 0.8× 247 0.6× 228 0.8× 23 1.3k
Miguel Ángel Cuesta-Geijo Spain 18 286 0.4× 133 0.2× 434 0.9× 195 0.5× 165 0.6× 26 1.2k

Countries citing papers authored by Holly A. Saffran

Since Specialization
Citations

This map shows the geographic impact of Holly A. Saffran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly A. Saffran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly A. Saffran more than expected).

Fields of papers citing papers by Holly A. Saffran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly A. Saffran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly A. Saffran. The network helps show where Holly A. Saffran may publish in the future.

Co-authorship network of co-authors of Holly A. Saffran

This figure shows the co-authorship network connecting the top 25 collaborators of Holly A. Saffran. A scholar is included among the top collaborators of Holly A. Saffran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly A. Saffran. Holly A. Saffran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joyce, Michael, et al.. (2024). Peptide Aldehydes Incorporating Thiazol-4-yl Alanine Are Potent In Vitro Inhibitors of SARS-CoV-2 Main Protease. ACS Medicinal Chemistry Letters. 15(11). 2046–2052.
2.
Arutyunova, Elena, Pu Chen, Muhammad Bashir Khan, et al.. (2023). The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism. SHILAP Revista de lepidopterología. 3(6). 528–541. 3 indexed citations
3.
Xu, Danyang, María Licursi, Michael Joyce, et al.. (2023). Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection. Frontiers in Immunology. 14. 930086–930086. 5 indexed citations
4.
Law, John Lok Man, Michael Logan, Michael Joyce, et al.. (2021). SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1. Vaccine. 39(40). 5769–5779. 24 indexed citations
5.
Vuong, Wayne, Conrad Fischer, Muhammad Bashir Khan, et al.. (2021). Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. European Journal of Medicinal Chemistry. 222. 113584–113584. 65 indexed citations
6.
Vuong, Wayne, Muhammad Bashir Khan, Conrad Fischer, et al.. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications. 11(1). 4282–4282. 340 indexed citations
7.
Pang, Bo, Jingyang Xu, Yan‐Ming Liu, et al.. (2020). Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology. Analytical Chemistry. 92(24). 16204–16212. 210 indexed citations
8.
Dauber, Bianca, Holly A. Saffran, & James R. Smiley. (2019). The herpes simplex virus host shutoff (vhs) RNase limits accumulation of double stranded RNA in infected cells: Evidence for accelerated decay of duplex RNA. PLoS Pathogens. 15(10). e1008111–e1008111. 23 indexed citations
9.
Enwere, Emeka K., Holly A. Saffran, Bart Hazes, et al.. (2018). Expression of the Vaccinia Virus Antiapoptotic F1 Protein Is Blocked by Protein Kinase R in the Absence of the Viral E3 Protein. Journal of Virology. 92(19). 3 indexed citations
10.
11.
12.
Dauber, Bianca, Holly A. Saffran, & James R. Smiley. (2014). The Herpes Simplex Virus 1 Virion Host Shutoff Protein Enhances Translation of Viral Late mRNAs by Preventing mRNA Overload. Journal of Virology. 88(17). 9624–9632. 36 indexed citations
13.
Saffran, Holly A., G. Sullivan Read, & James R. Smiley. (2010). Evidence for Translational Regulation by the Herpes Simplex Virus Virion Host Shutoff Protein. Journal of Virology. 84(12). 6041–6049. 33 indexed citations
14.
Saffran, Holly A., Justin M. Pare, Jennifer A. Corcoran, Sandra K. Weller, & James R. Smiley. (2006). Herpes simplex virus eliminates host mitochondrial DNA. EMBO Reports. 8(2). 188–193. 115 indexed citations
15.
Hsu, Wei‐Li, Holly A. Saffran, & James R. Smiley. (2005). Herpes Simplex Virus Infection Stabilizes Cellular IEX-1 mRNA. Journal of Virology. 79(7). 4090–4098. 14 indexed citations
16.
Saffran, Holly A., et al.. (2003). Evaluation of 5-[1-(2-Halo(or nitro)ethoxy-2-iodoethyl)]-2′-deoxyuridines as Inhibitors of Herpes Simplex Virus. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(1). 41–45. 3 indexed citations
17.
Smiley, James R., Mabrouk Elgadi, & Holly A. Saffran. (2001). Herpes Simplex Virus vhs Protein. Methods in enzymology on CD-ROM/Methods in enzymology. 342. 440–451. 38 indexed citations
18.
19.
Jones, Frank E., et al.. (2001). Herpes Simplex Virus Virion Host Shutoff Protein Requires a Mammalian Factor for Efficient In Vitro Endoribonuclease Activity. Journal of Virology. 75(3). 1172–1185. 25 indexed citations
20.
Mossman, Karen, Holly A. Saffran, & James R. Smiley. (2000). Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon. Journal of Virology. 74(4). 2052–2056. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur S. Kim Breakdown of academic impact, for papers by Masatsugu Kimura Breakdown of academic impact, for papers by Robert A. Ogert Breakdown of academic impact, for papers by Oliver C. Grant Breakdown of academic impact, for papers by Xufang Deng Breakdown of academic impact, for papers by Beatrice Mercorelli Breakdown of academic impact, for papers by Gary N. Rogers Breakdown of academic impact, for papers by Chengjin Ye Breakdown of academic impact, for papers by Zongyang Lv Breakdown of academic impact, for papers by Miguel Ángel Cuesta-Geijo
Rankless by CCL
2026